ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

KTTA Pasithea Therapeutics Corporation

6.92
0.00 (0.00%)
06 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Pasithea Therapeutics Corporation KTTA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 6.92 09:00:00
개장가 저가 고가 종가 전일 종가
6.92
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/04/202420:59GLOBEPasithea Therapeutics Announces PAS-004 Abstract Accepted..
24/04/202420:59GLOBEPasithea Therapeutics Announces the First Cohort has..
02/03/202411:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202411:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202411:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202411:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202421:59GLOBEPasithea Therapeutics Announces Opening of Enrollment in the..
19/01/202406:30EDGAR2Form 8-K - Current report
08/01/202421:59GLOBEPasithea Therapeutics Announces Invention of Crystalline..
03/01/202406:47EDGAR2Form 8-K - Current report
02/01/202422:35GLOBEPasithea Therapeutics Announces FDA Acceptance of IND..
29/12/202307:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/12/202307:00GLOBEPasithea Therapeutics Announces Adjournment of Reconvened..
29/12/202301:30EDGAR2Form 8-K - Current report
20/12/202307:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/12/202307:21EDGAR2Form 8-K - Current report
20/12/202307:19GLOBEPasithea Therapeutics Announces Results from 2023 Annual..
11/12/202322:01GLOBEPasithea Therapeutics Announces Positive In Vivo Preclinical..
30/11/202307:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/11/202306:27GLOBEPasithea Therapeutics Announces Adjournment of 2023 Annual..
29/11/202321:59GLOBEPasithea Therapeutics Announces Outcome of Pre-IND Meeting..
14/11/202306:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:59GLOBEPasithea Therapeutics Selects PAS-003 Lead Development..
27/10/202306:01EDGAR2Form ARS - Annual Report to Security Holders
27/10/202306:00EDGAR2Form DEF 14A - Other definitive proxy statements
17/10/202306:18EDGAR2Form PRE 14A - Other preliminary proxy statements
14/10/202306:00EDGAR2Form 8-K - Current report
14/09/202322:15EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
14/09/202322:11EDGAR2Form 8-K - Current report
14/09/202321:30GLOBEPasithea Therapeutics Corp. Announces Final Results of..
08/09/202305:14GLOBEPasithea Therapeutics to Participate in H.C. Wainwright 25th..
25/08/202306:00EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
22/08/202306:22EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
14/08/202322:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
12/08/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202322:08EDGAR2Form SC TO-I - Tender offer statement by Issuer
01/08/202320:59GLOBEPasithea Therapeutics publishes study in Proceedings of the..
20/07/202322:03EDGAR2Form SC TO-C - Written communication relating to an issuer..
20/07/202321:56EDGAR2Form 8-K - Current report
20/07/202321:43GLOBEPasithea Therapeutics Announces Intention to Commence a..
20/07/202321:40GLOBEPasithea Therapeutics Special Committee Rejects Unsolicited..
20/07/202321:31EDGAR2Form 8-K - Current report
04/07/202306:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/06/202322:28GLOBEPasithea Therapeutics Confirms Previous Creation of..
30/06/202303:50GLOBELucy Scientific Discovery Reiterates Its Proposal to Acquire..
29/06/202321:29GLOBEPasithea Therapeutics Announces Completion of GMP..
07/06/202305:30GLOBEPasithea Therapeutics Confirms Receipt of Unsolicited..
05/06/202322:00GLOBELucy Scientific Discovery Announces Proposal to Acquire..
01/06/202320:57GLOBEPasithea Therapeutics Abstract Accepted for Poster..

최근 히스토리

Delayed Upgrade Clock